To release chronic and
discomfort pain and
to get patients' and
their family's smile back

About AlphaNavi Pharma

Our mission to get patients' and their family's smiles back through the research & development of innovative novel drugs

News

2023/10/25
- Press release
AlphaNavi Pharma Exercises Option Regarding DSP-3905 under Development for Neuropathic Pain from Sumitomo Pharma
Sumitomo Pharma Co., Ltd. (Head Office: Osaka, Japan; Representative Director, President and CEO: Hiroshi Nomu …
2023/03/01
- Press release
Series B Round of Financing
AlphaNavi Pharma Inc. (“AlphaNavi”) (Head Office: Osaka, Japan; President and CEO: Yoshihiro Oyamada) announce …
2021/05/11
- information
AlphaNavi Pharma Inc., Announces Initiation of a Phase 1/2 Clinical Trial of ANP-230 in Patients with Familial Infantile Episodic Limb Pain
AlphaNavi Pharma Inc. (Headquarter: Sakyo-ku, Kyoto, Japan; CEO: Yoshihiro Oyamada) today announced the initia …